Medical Procedure Pricing & Benchmarks
Browse standard pricing benchmarks for high-volume outpatient visits, surgical interventions, diagnostic imaging, and routine therapies. Grounded in verified nationwide claims data.
Highest-Volume Medical Procedures
Ranked by annual nationwide patient volume
Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count.
Routine follow-up consultation with an established physician for ongoing or complex care.
Ground mileage, per statute mile.
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml.
Standard follow-up consultation with an established physician for minor or routine symptoms.
Guided therapeutic exercises restoring muscle strength, endurance, and range of motion.
Injection, certolizumab pegol, 1 mg (code may be used for standard insurance when drug administered under the direct supervision of a physician, not for use when drug is self administered).
Injection, gadoterate meglumine, 0.1 ml.
Injection, denosumab, 1 mg.
Injection, ferric carboxymaltose, 1 mg.
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled.
Injection, onabotulinumtoxina, 1 unit.
Standard collection of venous blood samples for medical laboratory testing.
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use).
Dynamic movement training improving daily functional tasks and workplace mechanics.
Subsequent daily hospital bedside visit monitoring acute medical treatment progress.
Injection, daptomycin, 1 mg.
Injection, faricimab-svoa, 0.1 mg.
Injection, tocilizumab, 1 mg.
Balance, coordination, and posture training to restore nerve-to-muscle communication.
Hands-on joint mobilization, therapeutic massage, and myofascial release techniques.
Injection, pembrolizumab, 1 mg.
Blood test, comprehensive group of blood chemicals.
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count.
Injection, testosterone cypionate, 1 mg.
Subsequent daily hospital bedside care managing severe or unstable inpatient conditions.
Injection, romosozumab-aqqg, 1 mg.
Injection, darbepoetin alfa, 1 microgram (non-esrd use).
Injection, gadobutrol, 0.1 ml.
Destruction of precancer skin growth, 2-14 growths.
Injection, golimumab, 1 mg, for intravenous use.
Pathology examination of tissue using a microscope, intermediate complexity.
Blood test, lipids (cholesterol and triglycerides).
Injection, triamcinolone acetonide, not otherwise specified, 10 mg.
Injection, dexamethasone sodium phosphate, 1 mg.
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only.
Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified.
Blood test, thyroid stimulating hormone (tsh).
Injection, iron sucrose, 1 mg.
Single-angle radiographic imaging of heart, lungs, and chest wall.
Injection, abatacept, 10 mg (code may be used for standard insurance when drug administered under the direct supervision of a physician, not for use when drug is self administered).
Chiropractic manipulative treatment, 3-4 spinal regions.
Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes.
Injection, fosaprepitant, 1 mg.
Professional administration of annual seasonal influenza vaccine.
Comprehensive first-time evaluation with a new doctor, reviewing medical history and symptoms.
Extended, comprehensive consultation with an established physician for high-complexity health management.
Chloroprocaine hcl ophthalmic, 3% gel, 1 mg.
Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes.
12-lead electrical tracing evaluating heart rhythm, conduction, and previous cardiac injury.
Yearly wellness review updating your personalized prevention plan and screening schedule.
Initial comprehensive physician examination upon admission to hospital inpatient care.
Established patient complete exam of visual system.
Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg.
Injection, nivolumab, 1 mg.
Emergency physician care for acute, potentially life-threatening illness or severe trauma.
Detection test by nucleic acid for organism, amplified probe technique.
Injection, aprepitant, 1 mg.
Standard first-time evaluation with a new physician for a specific health issue.